Literature DB >> 21177906

Overestimation of incidence of hepatitis B virus mixed-genotype infections by use of the new line probe INNO-LiPA genotyping assay.

Mélanie Mercier1, Syria Laperche, Annie Girault, Camille Sureau, Annabelle Servant-Delmas.   

Abstract

The new version of the INNO-LiPA HBV genotyping assay (Innogenetics) developed to identify all hepatitis B virus (HBV) genotypes, A to H, has been evaluated in comparison with sequencing of PCR-amplified HBV DNA from 200 samples before or after cloning. The genotyping data obtained with INNO-LiPA were in agreement with those from direct sequencing in the 179 samples characterized by the two methods. INNO-LiPA revealed 28 mixed infections. However, sequencing after molecular cloning confirmed only 15 of them and did not identify any that were of genotype H (n = 9). Our study demonstrates that INNO-LiPA overestimates mixed infections as a result of erroneous genotype H detection.

Entities:  

Mesh：

Year:  2010        PMID： 21177906      PMCID： PMC3067688          DOI： 10.1128/JCM.01888-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

Review 1.  [Hepatitis B virus genotypes: clinical, epidemiological and therapeutic implications].

Authors:  Philippe Halfon; Stanislas Pol; Marc Bourlière; Patrice Cacoub
Journal:  Gastroenterol Clin Biol       Date:  2002-11

2.  Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen status.

Authors:  P Halfon; M Bourlière; S Pol; Y Benhamou; D Ouzan; M Rotily; H Khiri; C Renou; G Pénaranda; D Saadoun; V Thibault; J Serpaggi; M Varastet; M-H Tainturier; T Poynard; P Cacoub
Journal:  J Viral Hepat       Date:  2006-05       Impact factor: 3.728

3.  Hepatitis B virus (HBV) genotyping in Belgian patients with chronic HBV infection.

Authors:  M I Micalessi; L De Cock; R Vranckx
Journal:  Clin Microbiol Infect       Date:  2005-06       Impact factor: 8.067

4.  Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes.

Authors:  Helene Norder; Anne-Marie Couroucé; Pierre Coursaget; José M Echevarria; Shou-Dong Lee; Isa K Mushahwar; Betty H Robertson; Stephen Locarnini; Lars O Magnius
Journal:  Intervirology       Date:  2004       Impact factor: 1.763

5.  National survey of hepatitis B virus (HBV) polymorphism in asymptomatic HBV blood donors from 1999 to 2007 in France.

Authors:  Annabelle Servant-Delmas; Mélanie Mercier; Marie-Hélène El Ghouzzi; Annie Girault; Françoise Bouchardeau; Josiane Pillonel; Syria Laperche
Journal:  Transfusion       Date:  2010-12       Impact factor: 3.157

6.  Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes.

Authors:  H Norder; A M Couroucé; L O Magnius
Journal:  Virology       Date:  1994-02       Impact factor: 3.616

7.  Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen.

Authors:  Mariacarmela Solmone; Donatella Vincenti; Mattia Carlo Felice Prosperi; Alessandro Bruselles; Giuseppe Ippolito; Maria Rosaria Capobianchi
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

8.  Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America.

Authors:  Patricia Arauz-Ruiz; Helene Norder; Betty H Robertson; Lars O Magnius
Journal:  J Gen Virol       Date:  2002-08       Impact factor: 3.891

9.  Analysis of hepatitis B genotype changes in chronic hepatitis B infection: Influence of antiviral therapy.

Authors:  Rosendo Jardi; Francisco Rodriguez-Frias; Melanie Schaper; Elena Giggi; David Tabernero; Maria Homs; Rafael Esteban; Maria Buti
Journal:  J Hepatol       Date:  2008-05-06       Impact factor: 25.083

10.  Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients.

Authors:  Severine Margeridon-Thermet; Nancy S Shulman; Aijaz Ahmed; Rajin Shahriar; Tommy Liu; Chunlin Wang; Susan P Holmes; Farbod Babrzadeh; Baback Gharizadeh; Bozena Hanczaruk; Birgitte B Simen; Michael Egholm; Robert W Shafer
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226
View more
  5 in total

1.  Revision of interpretation criteria of the INNO-LiPA HBV genotyping assay.

Authors:  Joke Doutreloigne; Elien Van Hecke; Mélanie Mercier; Syria Laperche
Journal:  J Clin Microbiol       Date:  2011-09       Impact factor: 5.948

Review 2.  Screening and diagnosis of HBV in low-income and middle-income countries.

Authors:  Jean-Pierre Allain; Ohene Opare-Sem
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

3.  Pattern of prevalent Hepatitis B virus genotypes in Zaria, Nigeria.

Authors:  Abdurrahman Elfulaty Ahmad; Adamu Girei Bakari; Bolanle Olufunke Priscilla Musa; Shettima Kagu Mustapha; Bello Yusuf Jamoh; Idris Nasir Abdullahi; Mohammed Ibrahim Tahir; Abdulqadri Olarenwaju Olatunji; Sumayya Hamza Maishanu; Ahmed Babangida Suleiman; Afolaranmi Tolulope; Claudia Hawkins; Atiene Solomon Sagay; Ayuba Zoakah; Adebola Tolulope Olayinka
Journal:  Niger Postgrad Med J       Date:  2019 Apr-Jun

4.  A SNaPshot assay for the rapid and simple detection of hepatitis B virus genotypes.

Authors:  Guoqi Lai; Wenlu Zhang; Hong Tang; Tingting Zhao; Liwen Wei; Ying Tao; Zengchan Wang; Ailong Huang
Journal:  Mol Med Rep       Date:  2014-07-14       Impact factor: 2.952

5.  A New Method for Next-Generation Sequencing of the Full Hepatitis B Virus Genome from A Clinical Specimen: Impact for Virus Genotyping.

Authors:  Flavia Hebeler-Barbosa; Ivan Rodrigo Wolf; Guilherme Targino Valente; Francisco Campello do Amaral Mello; Elisabeth Lampe; Maria Inês de Moura Campos Pardini; Rejane Maria Tommasini Grotto
Journal:  Microorganisms       Date:  2020-09-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.